These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 12407596)

  • 1. Prevention and treatment of hepatitis C in injection drug users.
    Edlin BR
    Hepatology; 2002 Nov; 36(5 Suppl 1):S210-9. PubMed ID: 12407596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hepatitis C virus infections in intravenous drug users.
    Robaeys G; Matheï C; Buntinx F; Vanranst M
    Acta Gastroenterol Belg; 2002; 65(2):99-100. PubMed ID: 12148448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
    Edlin BR; Kresina TF; Raymond DB; Carden MR; Gourevitch MN; Rich JD; Cheever LW; Cargill VA
    Clin Infect Dis; 2005 Apr; 40 Suppl 5(Suppl 5):S276-85. PubMed ID: 15768335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatitis C virus infection in incarcerated injection drug users.
    McGovern BH; Wurcel A; Kim AY; Schulze zur Wiesch J; Bica I; Zaman MT; Timm J; Walker BD; Lauer GM
    Clin Infect Dis; 2006 Jun; 42(12):1663-70. PubMed ID: 16705568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can HCV be prevented among injection drug users?
    Newmeyer J
    J Psychoactive Drugs; 2002; 34(4):421-5. PubMed ID: 12562111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirements.
    Grebely J; Matthews GV; Lloyd AR; Dore GJ
    Clin Infect Dis; 2013 Oct; 57(7):1014-20. PubMed ID: 23728143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to antiviral treatment in hepatitis C infected intravenous drug users.
    Gazdag G; Horvath G; Szabo O; Ungvari GS
    Neuropsychopharmacol Hung; 2010 Dec; 12(4):459-62. PubMed ID: 21220790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
    Iversen J; Grebely J; Topp L; Wand H; Dore G; Maher L
    J Viral Hepat; 2014 Mar; 21(3):198-207. PubMed ID: 24438681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
    Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B
    Int J Drug Policy; 2007 Oct; 18(5):437-43. PubMed ID: 17854734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States.
    Semaan S; Fleming P; Worrell C; Stolp H; Baack B; Miller M
    Drug Alcohol Depend; 2011 Nov; 118(2-3):100-10. PubMed ID: 21515001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C treatment for injection drug users: a review of the available evidence.
    Hellard M; Sacks-Davis R; Gold J
    Clin Infect Dis; 2009 Aug; 49(4):561-73. PubMed ID: 19589081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection drug users can be effectively treated for hepatitis C.
    Stancliff S
    Am Fam Physician; 2011 Mar; 83(6):647; author reply 648. PubMed ID: 21404974
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral treatment for chronic hepatitis C in illicit drug users: a systematic review.
    Zanini B; Lanzini A
    Antivir Ther; 2009; 14(4):467-79. PubMed ID: 19578232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.
    Munoz-Plaza CE; Strauss S; Astone-Twerell J; Jarlais DD; Gwadz M; Hagan H; Osborne A; Rosenblum A
    Int J Drug Policy; 2008 Feb; 19(1):71-8. PubMed ID: 18312822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
    Dore GJ; Thomas DL
    Semin Liver Dis; 2005 Feb; 25(1):18-32. PubMed ID: 15731995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.